Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

Johan Askling,C.M. Fored,Eva Baecklund,Lena Brandt,Carin Backlin,Anders Ekbom,Christer Sundström,L Bertilsson,Lars Cöster,P Geborek,L. Jacobsson,Staffan Lindblad,J Lysholm,Solbritt Rantapää-Dahlqvist,Tore Saxne,Lars Klareskog,Nils Feltelius

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

2005

Johan Askling
C.M. Fored
Eva Baecklund
Lena Brandt
Carin Backlin
Anders Ekbom
Christer Sundström
L Bertilsson
Lars Cöster
P Geborek
L. Jacobsson
Staffan Lindblad
J Lysholm
Solbritt Rantapää-Dahlqvist
Tore Saxne
Lars Klareskog
Nils Feltelius

BACKGROUND:Patients with rheumatoid arthritis (RA) are at increased risk of malignant lymphomas, and maybe also of leukaemia and multiple myeloma. The effect of tumour necrosis factor (TNF) antagon ...

Keywords:

Lymphoma
Physical therapy
Cancer research
Risk factor
Tumor necrosis factor alpha
Rheumatoid arthritis
Rheumatology
Malignancy
Haematopoiesis
Immunology
Internal medicine
Multiple myeloma
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

398

Citations